A5017761669- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Transplantation: Methods and Outcomes
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Medical Imaging and Pathology Studies
- Vascular Procedures and Complications
- Cardiovascular Issues in Pregnancy
- Cerebrovascular and Carotid Artery Diseases
- Parathyroid Disorders and Treatments
- Aortic aneurysm repair treatments
- Cardiac and Coronary Surgery Techniques
- Renal Transplantation Outcomes and Treatments
- Viral Infections and Immunology Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Pesticide Exposure and Toxicity
- Cardiac Arrhythmias and Treatments
- Aortic Disease and Treatment Approaches
- Cancer-related molecular mechanisms research
- Toxic Organic Pollutants Impact
- Neuroscience and Neuropharmacology Research
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
Institute of Nuclear Medicine & Allied Sciences
2021-2025
University of Iowa
2017-2018
MedStar Washington Hospital Center
2011
Fortis Hospital
2010
The use of biodegradable polymer drug-eluting stents (BP-DES) has been proven to minimize restenosis and stent thrombosis. current post-marketing monitoring was observed at the 5-year clinical outcomes individuals who had treated with FlexyRap® DES in real world.To assess safety effectiveness follow-up real-world settings.Findings from a retrospective, multi-center, observational, post-market study patients for de novo coronary artery disease (CAD) were reported. During 12-mo follow-up,...
Encountering a coronary subclavian steal syndrome phenomenon is rare opportunity. We came across three such cases. Article describes unique cases of two elderly males and one female who underwent CABG few years ago presented with recurrent chest pain symptoms.
Cardiovascular diseases (CVDs) became the leading cause of mortality in India, at turn century. This transition is largely because increase CVD risk factors India. Ischaemic heart disease burden Traditional anti-anginal drugs, classified as first line and second give symptom relief decreased frequency angina, however none prevents myocardial ischemia or death caused by coronary patients being treated specifically for chronic stable angina. The Diamond approach more acceptable it provides an...